Is Xometry (XMTR) Pricing Still Justified After Recent Share Price Declines?

• If you are wondering whether Xometry's share price still makes sense after recent swings, you are not alone. This article is going to focus squarely on what you are really paying for in the business.
• The stock last closed at US$41.82, with a 7 day return of 27.4% decline, a 30 day return of 34.7% decline, a year to date return of 33.4% decline, a 1 year return of 54.8%, and a 3 year return of 127.3%.
• Recent coverage has highlighted Xometry's position as an online marketplace for manufacturing services and the market's interest in how its business model scales over time. That context helps explain why the share price can move sharply as investors reassess growth potential and risk.
• On our simple 6 point valuation checklist, Xometry scores 2 out of 6 on undervaluation, which you can see in detail in our valuation score. Next we will look at the key valuation methods behind that result and then finish with a view on an alternative way to think about what the stock might be worth.

Xometry scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Xometry Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a business could be worth today by projecting its future cash flows and then discounting those back into today's dollars.

For Xometry, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is a loss of about US$21 million. Analyst and extrapolated projections, provided in the model, show free cash flow figures running from a US$4 million loss in 2026 through to US$99 million in 2035, all in US$ terms. The later years are based on Simply Wall St estimates rather than direct analyst forecasts.

When those projected cash flows are discounted back and combined with a terminal value, the model arrives at an estimated intrinsic value of about US$25.71 per share. Compared with the recent share price of US$41.82, this implies the stock is around 62.7% above the DCF estimate. On this set of assumptions, this points to it being overvalued.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Xometry may be overvalued by 62.7%. Discover 53 high quality undervalued stocks or create your own screener to find better value opportunities.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Xometry.

Approach 2: Xometry Price vs Sales

For companies where earnings are not yet a reliable guide, the price to sales, or P/S, ratio is often a useful way to compare what the market is paying for each dollar of revenue. It sidesteps short term swings in profit and focuses on how investors value the current revenue base.

In general, higher growth expectations and lower perceived risk tend to justify a higher P/S ratio, while slower growth or higher risk often line up with a lower “normal” multiple. So it helps to see Xometry’s current P/S against a few anchors rather than in isolation.

Xometry trades on a P/S of 3.13x, compared with the Trade Distributors industry average of 1.30x and a peer average of 1.38x. Simply Wall St’s Fair Ratio for Xometry is 3.59x. This is its proprietary estimate of what the P/S could be given factors like growth expectations, profit margins, industry, market cap and specific risks. This Fair Ratio can be more informative than a simple peer or industry comparison because it adjusts for those company specific features instead of assuming all firms deserve the same multiple. With the current 3.13x P/S sitting below the 3.59x Fair Ratio, the shares screen as undervalued on this measure.

Result: UNDERVALUED

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 21 top founder-led companies.

Upgrade Your Decision Making: Choose your Xometry Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, which are simply your story about Xometry linked to your own forecast for revenue, earnings and margins, and then to a fair value that you can compare with the current share price. On Simply Wall St, within the Community page used by millions of investors, you can pick or create a Narrative, see the financial forecast that goes with it, and use the gap between Fair Value and Price to help decide whether the stock looks attractive or stretched for you personally, knowing that the Narrative will refresh as new earnings or news come in. For Xometry, one Narrative might anchor around the consensus fair value of about US$65.44 per share. A more optimistic Narrative could use the higher US$75.00 fair value, and seeing those side by side makes it clear how reasonable people can look at the same company, the same data and arrive at different conclusions about what the stock is worth today.

Do you think there's more to the story for Xometry? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com